{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Tookes HE"],"funding":["NIDA NIH HHS","NIAID NIH HHS","NIMH NIH HHS","National Cancer Institute","NCI NIH HHS","National Institute of Mental Health","National Institutes of Health","National Institute on Drug Abuse","Miami Center for Aids Research"],"pagination":["109124"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9102418"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["229(Pt A)"],"pubmed_abstract":["Background
People who inject drugs (PWID) have been a marginalized and a stigmatized population since the beginning of the AIDS epidemic and have not experienced the same life-changing benefits of antiretroviral therapy as others. Tele-Harm Reduction (THR) is a telehealth-enhanced, harm reduction intervention, delivered within a trusted SSP venue. It aims to facilitate initiation of care and achieve rapid HIV viral suppression among PWID living with HIV.Methods
In this mixed-methods study, we employed the Practical, Robust, Implementation and Sustainability Model (PRISM) implementation science framework to identify multilevel barriers and facilitators to implementing the THR intervention. Focus groups (n = 2, 16 participants), stakeholder interviews (n = 7) and in-depth int"],"journal":["Drug and alcohol dependence"],"pubmed_title":["Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs."],"pmcid":["PMC9102418"],"funding_grant_id":["DP2 DA053720","P30 AI073961","P30CA240139","P30AI073961","P30 CA240139","1 DP2 DA053720–01","3P30MH116867–01A1S1","R01 DA045713","P30 MH116867","UG1 DA013720"],"pubmed_authors":["Bartholomew TS","Kolber MA","Sternberg C","Forrest DW","Boyd D","Rodriguez A","Mooss A","Metsch LR","Serota DP","Suarez E","Ginoza M","Tookes HE","Ekowo E","Feaster DJ"],"additional_accession":[]},"is_claimable":false,"name":"Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs.","description":"Background
People who inject drugs (PWID) have been a marginalized and a stigmatized population since the beginning of the AIDS epidemic and have not experienced the same life-changing benefits of antiretroviral therapy as others. Tele-Harm Reduction (THR) is a telehealth-enhanced, harm reduction intervention, delivered within a trusted SSP venue. It aims to facilitate initiation of care and achieve rapid HIV viral suppression among PWID living with HIV.Methods
In this mixed-methods study, we employed the Practical, Robust, Implementation and Sustainability Model (PRISM) implementation science framework to identify multilevel barriers and facilitators to implementing the THR intervention. Focus groups (n = 2, 16 participants), stakeholder interviews (n = 7) and in-depth int","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Dec","modification":"2026-06-04T04:41:09.034Z","creation":"2025-04-04T19:37:50.968Z"},"accession":"S-EPMC9102418","cross_references":{"pubmed":["34781096"],"doi":["10.1016/j.drugalcdep.2021.109124"]}}